Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 4, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Animal models for benign prostatic hyperplasia.

J Paul Hieble1

  • 1Department of Urology Research, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA, 19406, USA.

Handbook of Experimental Pharmacology
|February 4, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of bladder function by prostaglandin EP3 receptors in the central nervous system.

American journal of physiology. Renal physiology·2008
Same author

An excitatory role for peripheral EP3 receptors in bladder afferent function.

American journal of physiology. Renal physiology·2008
Same author

AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome.

American journal of physiology. Renal physiology·2008
Same author

Analysis of efficacy of chiral adrenergic agonists.

Chirality·2008
Same author

The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder.

European journal of pharmacology·2007
Same author

GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.

The Journal of pharmacology and experimental therapeutics·2007
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Animal models are crucial for benign prostatic hyperplasia (BPH) research, aiding drug development. New models focusing on cellular growth are needed for better BPH therapies.

Area of Science:

  • Urology
  • Pharmacology
  • Animal Modeling

Background:

  • Benign prostatic hyperplasia (BPH) etiology remains unknown.
  • Animal models have historically aided BPH therapeutic development.
  • Current BPH treatments include α-adrenoceptor antagonists and 5-α-reductase inhibitors.

Purpose of the Study:

  • To review the utility of animal models in BPH research.
  • To identify limitations of current BPH models.
  • To highlight the need for improved animal models focusing on cellular mechanisms.

Main Methods:

  • Review of existing literature on animal models for BPH.
  • Categorization of models based on measured outcomes (smooth muscle tone vs. cellular proliferation).
  • Analysis of the role of animal models in developing current BPH drugs.

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Main Results:

  • Animal models were instrumental in developing approved BPH drug classes.
  • Prostatic tone models have limited success in identifying novel α-adrenoceptor antagonists.
  • A key limitation is the lack of spontaneous or inducible BPH in animals mimicking the human condition.

Conclusions:

  • Existing BPH animal models have limitations, particularly in predicting new drug efficacy.
  • Future BPH research requires models that better reflect human prostatic cellular growth.
  • Developing improved animal models is essential for advancing BPH treatment strategies.